• Home
  • Community
  • Services
  • Eye Conditions
    • Vision Conditions
    • Patient Resources
    • Eye Diseases
  • Forms
  • Appointments
  • Meet the Doctors
  • Vision Therapy
  • Specialty Lenses
  • Designer Frames
  • Contact
  • Office Hours & Locations
  • Office Tour - Grove Ave.
  • Office Tour - Midlothian
  • Insurance

Patient Resources

 
  • American Optometric Association
  • InfantSEE Program
  • EyeCare America
  • EyeSmart
  • Letter for AREDS participants
  • National Eye Institute
  • Familydoctor.org
  • Macular Degeneration Foundation
  • Glaucoma Foundation
  • Macular Degeneration Partnership
  • Foundation Fighting Blindness
  • Lighthouse International
  • Glaucoma Research Foundation
  • National Keratoconus Foundation
  • Eye Supplements

Letter for AREDS Participants

Letter for AREDS participants in reply to vitamin E study
A recent meta-analysis of 19 studies reports that daily doses of vitamin E above 400IU are associated with an increased risk of death. However, the authors of the Age-Related Eye Disease Study (AREDS) say this new analysis doesn’t apply to patients at risk for advanced AMD. They are advising patients taking 400IU of vitamin E as part of the AREDS formulation to continue.

 

 
 
 

Copyright © 2012 Grove Avenue Eye Center. All Rights Reserved.

Website Managed and Created by Defiant Creative.